CE-108, a new macrolide tetraene antibiotic

Area of Science:

• Microbiology
• Natural Product Chemistry
• Medicinal Chemistry

Background:

• Streptomyces species are a prolific source of bioactive natural products, including antibiotics.
• The search for novel antifungal agents is crucial due to the rise of resistant fungal infections.
• Tetraene macrolides are a class of antifungal compounds known for their polyene structure.

Purpose of the Study:

• To isolate and characterize a novel antifungal compound from Streptomyces diastaticus.
• To investigate the production of this new compound and its relationship with known compounds.
• To determine the structural features and biological properties of the novel macrolide.

Main Methods:

• Isolation of compounds from Streptomyces diastaticus culture broth.
• Fermentation optimization by modifying medium composition.
• Purification techniques including chromatography.
• Structure elucidation using spectroscopic methods (e.g., NMR, Mass Spectrometry).
• Determination of biological activity, specifically antifungal properties.

Main Results:

• A new tetraene macrolide, designated CE-108, was successfully isolated.
• Streptomyces diastaticus 108 was identified as the producer strain.
• The strain also produced known compounds: rimocidin and oxytetracycline.
• CE-108 and rimocidin were produced in a ratio of 25-35%, which could be manipulated by altering fermentation media.
• Structural characterization confirmed CE-108 as a novel tetraene macrolide.

Conclusions:

• A new antifungal tetraene macrolide, CE-108, has been discovered from Streptomyces diastaticus.
• The production of CE-108 can be modulated by adjusting fermentation conditions, offering potential for yield improvement.
• This discovery contributes to the library of antifungal compounds and provides a new lead for therapeutic development.